NEW YORK (360Dx) – OncoDNA said this week that new guidelines from the Spanish Society of Pathology and the Spanish Society of Medical Oncology now endorse genomic testing to identify cancers of unknown primary origin using tools like OncoDNA's OncoDEEP product — a combined DNA and protein assay performed on solid tumor samples.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.